- Investing Ideas
- /
- Commercial Services Healthcare Sector
Commercial Services Healthcare Sector
Results
2304
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2304 companies
Dynavax Technologies
Market Cap: US$1.2b
A commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally.
DVAX
US$9.82
7D
3.3%
1Y
-17.1%
Kestra Medical Technologies
Market Cap: US$1.2b
Operates as a wearable medical device and digital healthcare company.
KMTS
US$22.30
7D
-6.1%
1Y
n/a
ANI Pharmaceuticals
Market Cap: US$1.2b
A biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.
ANIP
US$57.27
7D
-3.8%
1Y
-5.1%
U.S. Physical Therapy
Market Cap: US$1.2b
Operates and manages outpatient physical therapy clinics.
USPH
US$75.40
7D
-3.7%
1Y
-25.0%
Pulse Biosciences
Market Cap: US$1.2b
Operates as a novel bioelectric medicine company.
PLSE
US$16.86
7D
2.2%
1Y
41.1%
Ocular Therapeutix
Market Cap: US$1.2b
A biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States.
OCUL
US$7.22
7D
0.6%
1Y
24.4%
Novavax
Market Cap: US$1.2b
A biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally.
NVAX
US$7.29
7D
15.9%
1Y
-51.9%
Amphastar Pharmaceuticals
Market Cap: US$1.1b
A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.
AMPH
US$24.20
7D
-0.5%
1Y
-44.2%
Natus Medical
Market Cap: US$1.1b
Natus Medical Incorporated provides medical device solutions focuses on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide.
NTUS
US$32.96
7D
0.8%
1Y
34.4%
Aurinia Pharmaceuticals
Market Cap: US$1.1b
A biopharmaceutical company that engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs.
AUPH
US$8.27
7D
1.5%
1Y
57.8%
Viridian Therapeutics
Market Cap: US$1.1b
Engages in discovering, developing, and commercializing treatments for serious and rare diseases.
VRDN
US$13.67
7D
8.3%
1Y
12.4%
Mineralys Therapeutics
Market Cap: US$1.1b
A clinical-stage biopharmaceutical company, develops medicines to target diseases driven by dysregulated aldosterone in the United States.
MLYS
US$16.32
7D
6.3%
1Y
33.4%
Aveanna Healthcare Holdings
Market Cap: US$1.1b
A diversified home care platform company, provides pediatric and adult healthcare services in the United States.
AVAH
US$5.35
7D
-10.8%
1Y
97.4%
BioLife Solutions
Market Cap: US$1.1b
Develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.
BLFS
US$22.10
7D
0.5%
1Y
4.8%
Spire Healthcare Group
Market Cap: UK£778.2m
Owns and operates private hospitals and clinics in the United Kingdom.
SPI
UK£1.91
7D
-3.9%
1Y
-25.0%
Establishment Labs Holdings
Market Cap: US$1.0b
A medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgeries.
ESTA
US$36.85
7D
0.6%
1Y
-30.6%
Neuren Pharmaceuticals
Market Cap: AU$1.6b
A biopharmaceutical company, develops drugs for the treatment of neurological disorders.
NEU
AU$12.87
7D
-2.4%
1Y
-37.9%
OPKO Health
Market Cap: US$1.0b
A healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally.
OPK
US$1.27
7D
-4.5%
1Y
-0.8%
10x Genomics
Market Cap: US$1.0b
A life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific.
TXG
US$8.54
7D
-7.2%
1Y
-62.8%
MiMedx Group
Market Cap: US$1.0b
Develops and distributes placental tissue allografts for various sectors of healthcare.
MDXG
US$6.72
7D
-5.2%
1Y
-13.5%
Craneware
Market Cap: UK£740.7m
Develops, licenses, and supports computer software for the healthcare industry in the United States.
CRW
UK£20.70
7D
-6.3%
1Y
-7.2%
Pennant Group
Market Cap: US$986.8m
Provides healthcare services in the United States.
PNTG
US$28.06
7D
-4.6%
1Y
23.8%
Integra LifeSciences Holdings
Market Cap: US$986.2m
Manufactures and sells surgical instrument, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology.
IART
US$12.66
7D
-2.7%
1Y
-55.6%
Harrow
Market Cap: US$981.0m
An eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products.
HROW
US$25.74
7D
0.5%
1Y
47.1%
agilon health
Market Cap: US$972.8m
Provides healthcare services for seniors through primary care physicians in the communities of the United States.
AGL
US$2.20
7D
-13.7%
1Y
-61.1%
Oculis Holding
Market Cap: US$971.5m
A clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic diseases in Switzerland, Iceland, and internationally.
OCS
US$17.95
7D
-1.9%
1Y
50.8%
Ardelyx
Market Cap: US$954.6m
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
ARDX
US$3.96
7D
17.2%
1Y
-46.8%
Intellia Therapeutics
Market Cap: US$953.0m
A clinical-stage gene editing company, focuses on the development of curative genome editing treatments.
NTLA
US$9.46
7D
17.2%
1Y
-62.0%
NeoGenomics
Market Cap: US$952.3m
Operates a network of cancer-focused testing laboratories in the United States and the United Kingdom.
NEO
US$7.28
7D
-7.1%
1Y
-47.6%
CareDx
Market Cap: US$949.4m
Engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally.
CDNA
US$17.11
7D
6.3%
1Y
8.1%
Collegium Pharmaceutical
Market Cap: US$947.2m
A specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.
COLL
US$28.82
7D
-1.8%
1Y
-14.8%
Phibro Animal Health
Market Cap: US$942.4m
Operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally.
PAHC
US$23.02
7D
-3.4%
1Y
24.7%
Nutex Health
Market Cap: US$940.6m
Operates as a physician-led, healthcare services, and operations company in the United States.
NUTX
US$161.86
7D
-6.8%
1Y
2,087.3%
Wave Life Sciences
Market Cap: US$931.0m
A clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform.
WVE
US$6.09
7D
-3.3%
1Y
0%
Evolent Health
Market Cap: US$926.9m
Through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States.
EVH
US$7.36
7D
-16.6%
1Y
-67.8%
Syndax Pharmaceuticals
Market Cap: US$916.4m
A commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer.
SNDX
US$10.81
7D
20.8%
1Y
-46.2%